Biopharmaceutical Company
Appears in 1 story · Last updated Jul 16, 2026
As of July 2026: Developer of soficitinib, moving toward regulatory filing
Millions of people with severe eczema live with relentless itching and raw, inflamed skin. On July 15, 2026, InnoCare Pharma said its once-daily pill, soficitinib, hit the main goal of a late-stage trial in that group.
Updated Jul 15
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
